Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000043918 |
|---|---|
| Receipt number | R000050137 |
| Scientific Title | A prospective observational study to investigate the safety of SARS-CoV-2 vaccine in patients with lung cancer who are treated or will be treated with anticancer medication (OLCSG2102) |
| Date of disclosure of the study information | 2021/04/14 |
| Last modified on | 2024/06/19 19:04:35 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/04/14 11:51:55 | ||
| 2 | Update | 2021/10/17 17:44:24 | Date analysis concluded |
|
| 3 | Update | 2022/10/15 17:57:23 | Recruitment status |
|
| 4 | Update | 2023/10/16 12:57:33 | Number of participants that the trial has enrolled Outcome measures |
|
| 5 | Update | 2024/06/19 19:04:11 | Recruitment status |
|
| 6 | Update | 2024/06/19 19:04:35 | Publication of results |